ivomec razt za injic
boehringer ingelheim animal health france scs 29 avenue tony garnier 69007 lyon francija izdelovalec -
flebaven 1000 mg tablete
krka, d.d., novo mesto - diosmin - tableta - diosmin 1000 mg / 1 tableta - diosmin
flebaven 1000 mg tablete
krka, d.d., novo mesto - diosmin - tableta - diosmin 1000 mg / 1 tableta - diosmin
flebaven 500 mg filmsko obložene tablete
krka, d.d., novo mesto - diosmin - filmsko obložena tableta - diosmin 500 mg / 1 tableta - diosmin
flebaven 500 mg filmsko obložene tablete
krka, d.d., novo mesto - diosmin - filmsko obložena tableta - diosmin 500 mg / 1 tableta - diosmin
flebaven 1000 mg tablete
krka, d.d., novo mesto - diosmin - tableta - diosmin 1000 mg / 1 tableta - diosmin
flebaven 500 mg filmsko obložene tablete
krka, d.d., novo mesto - diosmin - filmsko obložena tableta - diosmin 500 mg / 1 tableta - diosmin
vendiomed 1000 mg filmsko obložene tablete
pharmaswiss Česká republika s.r.o. - diosmin - filmsko obložena tableta - diosmin 1000 mg / 1 tableta - diosmin
vendiomed 1000 mg filmsko obložene tablete
pharmaswiss Česká republika s.r.o. - diosmin - filmsko obložena tableta - diosmin 1000 mg / 1 tableta - diosmin
locametz
novartis europharm limited - gozetotide - radionuklidno slikanje - diagnostični radiofarmacevtiki - to zdravilo je samo za diagnostično uporabo. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.